European industries unite to call for an ambitious EU industrial strategy

26 November 2019

Biosimilars ‒ Policy failings that deny savings to countries that need it most

21 November 2019

‘Health revolution’: when smart innovation benefits patients

21 November 2019

Value added medicines conference urges paradigm shift across the healthcare […]

Medicines for Europe, APOGEN and Fresenius Kabi hold Open Industry Day in Portugal

14 November 2019

Almost 70% of medicines dispensed in Europe are generic medicines […]

Future and Challenges of the Pharmaceutical Industry

14 November 2019

Biosimilar medicines: competition, sustainability and early* access on the agenda of DG GROW stakeholder workshop

30 October 2019

Medicines for Europe welcomes 5th European Commission Stakeholder event on […]

WHO signs MoU with International Generic and Biosimilar Medicines Association to promote access

23 October 2019

Report identifies 9 key ingredients to improve access to medicines in the hospital setting

7 October 2019

Many European countries are grappling with the efficiency of hospital […]

EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement

30 September 2019

Brussels, 30 September 2019 – Amidst discussions on the International […]

Christoph Stoller (Teva) Appointed as new President of Medicines for Europe
Immediately calls on new President of EU Commission to prioritise Healthcare

25 September 2019

Christoph Stoller was elected as President of Medicines for Europe […]